Miebo represents a breakthrough in dry eye treatment by targeting tear evaporation with its innovative formulation. This FDA-approved eye drop improves eye comfort and supports ocular surface health by forming a protective barrier over your tears. Find a top optometrist or ophthalmologist near you to learn more about Miebo and how it can help you regain comfort and clarity.
Miebo is the first and only FDA-approved prescription eye drop that directly targets tear evaporation, the leading cause of dry eye disease. By forming a protective layer over your tears, this innovative, water-free treatment helps keep your eyes moist, relieve irritation, and improve the health of your ocular surface.
Miebo functions by enhancing the natural tear film to prevent excessive evaporation, addressing the core mechanism of most dry eye cases. This section explains its protective actions and how it contributes to overall eye comfort.
For most people with dry eye, the problem is not a lack of tears but rapid tear evaporation. A healthy tear film has a protective outer lipid (oil) layer that prevents the underlying watery part from drying out. When the oil glands in the eyelids do not function properly, this layer weakens, tears evaporate too quickly, and symptoms like burning, irritation, and blurred vision appear.
Miebo contains a single active ingredient, perfluorohexyloctane, a semifluorinated alkane that is both water-repelling and highly stable. When applied, it spreads rapidly over the eye and integrates with your natural oils to form a uniform, durable barrier. This barrier mimics the protective lipid layer, significantly slowing evaporation and stabilizing the tear film for hours.
By reducing tear evaporation, Miebo prevents the tears from becoming too salty (hyperosmolar). High osmolarity causes inflammation, surface damage, and symptoms like redness and burning. Miebo’s protective effect helps restore a healthier tear environment, giving the corneal and conjunctival cells a chance to repair and regenerate.
Miebo's drop size is much smaller than traditional water-based drops and spreads quickly and evenly. Because the drop is so small and contains no water, many users barely feel it when instilled, making dosing especially comfortable for those with sensitive eyes. There is usually no burning or stinging associated with the drop.
Miebo offers several unique advantages for patients with evaporative dry eye, from its targeted mechanism to its simple, gentle formula. These benefits highlight why it stands out as a preferred option for many patients seeking lasting comfort.
Unlike artificial tears that supplement moisture or anti-inflammatory drops that reduce swelling, Miebo directly prevents tear loss by stabilizing the lipid layer. This addresses the primary problem for most dry eye patients, leading to sustained relief rather than a temporary fix.
Miebo contains only 100% perfluorohexyloctane, with no water, preservatives, steroids, or other additives. This purity minimizes the risk of irritation, burning, or allergic reactions, especially for patients sensitive to chemicals found in other ophthalmic products.
When used four times a day as prescribed, Miebo provides ongoing protection throughout the day. Each dose remains on the eye for at least six hours, creating a durable barrier against evaporation that keeps working between doses and leads to sustained symptom improvement over time.
By protecting the eye from drying stress and reducing hyperosmolarity, Miebo allows damaged areas on the cornea to repair themselves. Clinical studies show that regular use leads to significant improvement in ocular surface health, which can improve comfort and, for some, clarity of vision.
Miebo is designed for adults with dry eye disease primarily caused by tear evaporation, which is often linked to Meibomian Gland Dysfunction (MGD). Your eye doctor will help determine if Miebo is the right choice for your specific condition.
You may be a good candidate for Miebo if you are an adult who fits one of the following profiles:
Do not use Miebo if you have active eye infections, severe inflammation, or a known allergy to perfluorohexyloctane. Pregnant or nursing individuals should consult their eye doctor before starting treatment.
Understanding how Miebo's unique mechanism differs from other dry eye treatments can help you and your doctor make the best choice for your symptoms. This comparison highlights the key distinctions between Miebo and other common eye drops.
Artificial tears temporarily add moisture to refresh the eye, but they do little to prevent that moisture from evaporating. Miebo does not add water; instead, it forms a protective barrier to hold your natural tears on the eye, providing more significant and longer-lasting relief from evaporative dry eye.
Prescription drops like Restasis (cyclosporine) treat inflammation and can help your body produce more of its own tears. This is helpful for aqueous-deficient dry eye. Miebo works independently by preventing tear evaporation and can be used in combination with anti-inflammatory drops for comprehensive management.
Over-the-counter lipid-based drops also aim to replenish the oils in the tear film. However, Miebo's semifluorinated alkane is a unique compound that forms a more durable and effective barrier against evaporation than the natural lipid-based products found in most artificial tears.
Ointments are thick, greasy, and provide long-lasting moisture, but they cause significant blurring and are typically reserved for overnight use. Miebo is a clear liquid intended for daytime use that does not interfere with vision, making it suitable for use during daily activities.
Steroid drops are potent anti-inflammatory agents used to quickly control flare-ups of inflammation. However, they can have side effects with long-term use. Miebo is not an anti-inflammatory; it focuses on tear film stabilization with minimal risk of side effects, making it suitable for chronic use.
Miebo has been rigorously tested in large clinical trials involving over 1,200 adults, showing it is both safe and effective for treating the signs and symptoms of dry eye disease. The results confirm its ability to provide fast, lasting relief while healing the ocular surface.
In two major clinical studies, GOBI and MOJAVE, Miebo demonstrated significant reductions in both patient-reported symptoms of dryness and objective signs of corneal damage. A separate one-year study confirmed that Miebo remains safe and effective with long-term, chronic use.
In clinical trials, many patients reported feeling relief from symptoms like burning and grittiness within minutes to an hour of the first dose. These improvements continued to build over the first few weeks of consistent use, with patients experiencing sustained relief throughout the study periods.
Miebo is generally well-tolerated. The most common side effect reported in clinical trials was temporary blurred vision, which occurred in fewer than 4% of users. Mild eye redness was reported in 1-3% of patients. No serious drug-related adverse events have been reported.
Don’t let dry eye discomfort hold you back from enjoying your day! Consult with one of the top eye doctors listed on Specialty Vision today to see if Miebo is the right solution for your needs. Find an optometrist or ophthalmologist near you now!
Using Miebo correctly is important for ensuring you get the maximum benefit and safety from your treatment. Follow these simple steps for proper application and dosing.
Always wash your hands thoroughly with soap and water before instilling eye drops. Remove the bottle cap carefully, making sure not to touch the dropper tip to any surface, including your fingers or eye, to prevent contamination.
If using a new bottle, you may need to prime it. Hold the bottle upright and squeeze gently. While still squeezing, turn the bottle upside down so the tip points down. Release the pressure to draw air into the bottle, which will form a small drop at the tip. This ensures the dropper is ready to dispense a single, accurate drop.
Keep the bottle upside down and tilt your head back. Gently pull down your lower eyelid to create a small pocket. Position the tip above your eye without letting it touch the surface, and gently squeeze to release one drop into the pocket. Blink gently a few times to spread the medication over the surface of the eye. Repeat for the other eye if needed.
The recommended dose is one drop in each affected eye four times a day. If you wear contact lenses, you must remove them before using Miebo and wait at least 30 minutes before reinserting them. If you miss a dose, use it as soon as you remember, but do not double up if it is almost time for your next scheduled dose.
If you are struggling with persistent dry eye symptoms and have not found sufficient relief, ask your eye doctor whether Miebo might be right for you. Your provider can assess your tear film, review your treatment history, and help you develop a personalized dry eye management plan.
Don’t let dry eye discomfort hold you back from enjoying your day! Consult with one of the top eye doctors listed on Specialty Vision today to see if Miebo is the right solution for your needs. Find an optometrist or ophthalmologist near you now!
Miebo offers targeted relief for dry eye by preventing tear evaporation. Discover how perfluorohexyloctane can enhance your eye care.
